Posts Tagged ‘patent box’

2018 budget: a tax update for biotech and tech businesses

Downing Street road sign

  Invitation to the essential 2018 post-budget briefing and general tax update for biotech and tech companies a free event We’ll keep it brief as you’re all busy but we’ll distill the significant bits of Chancellor Philip Hammond’s budget and discuss how they relate to biotech and tech businesses. The Confluence Tax team will be…

Read More

BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?

Union-Jack-flag-with-Brexit-word

THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…

Read More

Should your company elect in to the Patent Box?

Light bulbs hanging from a ceiling

You’re not out of time but don’t be out of touch… Bad Hall & Oates songs aside, the Patent Box is a complicated beast and 2018 is likely to be a crucial year for determining whether you should elect in. So here is some clarity if yours is a loss-making company. The Patent Box provides…

Read More

What’s next for UK tax post-election?

polling-station-photograph-2017

The UK general election result generated a lot of heat but did not shed much light on the future. The outcome for tax issues relating to biotechnology and technology businesses is clear and simple – no change.  Whatever a minority Conservative administration does, or is forced to do, in order to continue, there are no…

Read More

BioTrinity 2017 Confluence Tax

Confluence Tax will be attending BioTrinity 2017, Europe’s leading biopartnering and investment conference, May 8-10, Novotel London West. We’re looking forward to catching up with our clients and chatting to new delegates. Why not come by stand #35 we’re always happy to talk through the latest tax developments in relation to company structures, R&D tax credits, share schemes…

Read More